Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in ECT for Depression
NCT02012335Withdrawn
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in major depressive disorder (MDD) and bipolar disorder (BD) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Hamilton Depression Rating Scale 17. Planned start Jan 2014; status: withdrawn.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02012335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012335.